• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用快速认知筛查评估慢性阻塞性肺疾病患者的认知障碍。

Assessment of Cognitive Impairment in Patients with Chronic Obstructive Pulmonary Disease Using the Rapid Cognitive Screen.

机构信息

Edward Charbek, Saint Louis University, St. Louis, MO, USA, Email Address:

出版信息

J Nutr Health Aging. 2019;23(1):102-104. doi: 10.1007/s12603-018-1146-x.

DOI:10.1007/s12603-018-1146-x
PMID:30569077
Abstract

OBJECTIVES

To determine the prevalence of cognitive impairment in chronic obstructive pulmonary disease (COPD) patients using the Rapid Cognitive Screen (RCS).

DESIGN

Cross sectional study.

PARTICIPANTS

A total of 106 men and women with COPD 50 years of age or older.

SETTING

Pulmonary ambulatory clinic in a tertiary academic center in St. Louis, Missouri, USA.

MEASUREMENTS

We enrolled patients with COPD who completed the RCS tool. Patients were classified as having normal cognition, mild cognitive impairment (MCI), or dementia if they scored ≥ 8, 6-7, or ≤ 5, respectively. The prevalence of each category was measured, and patients' baseline characteristics were compared.

RESULTS

One hundred and six patients completed the RCS. Of those, 36 (33.9%) patients scored ≤ 5 on the RCS, 33 (31.1%) scored 6 or 7, and 37 (34.9%) scored ≥ 8. The prevalence of dementia, MCI, and normal cognition were 33.9%, 31.1%, and 34.9%, respectively. Baseline lung function was not different between patients with normal cognition and those with abnormal cognition (FEV1 1.53 ± 0.39 vs 1.45 ± 0.32 L). In patients with abnormal cognition, there was no difference in patients' characteristics between patients with MCI or dementia.

CONCLUSION

Cognitive impairment is highly prevalent in patients with COPD. RCS successfully identified cognitive impairment in COPD. We recommend performing RCS in patients with COPD routinely.

摘要

目的

使用快速认知筛查(RCS)确定慢性阻塞性肺疾病(COPD)患者认知障碍的患病率。

设计

横断面研究。

参与者

共 106 名年龄在 50 岁或以上的 COPD 男性和女性患者。

地点

美国密苏里州圣路易斯市三级学术中心的肺门诊。

测量方法

我们招募了完成 RCS 工具的 COPD 患者。如果患者的得分分别为≥8、6-7 或≤5,则将其归类为认知正常、轻度认知障碍(MCI)或痴呆。测量了每个类别的患病率,并比较了患者的基线特征。

结果

106 名患者完成了 RCS。其中,36 名(33.9%)患者的 RCS 得分≤5,33 名(31.1%)得分 6 或 7,37 名(34.9%)得分≥8。痴呆、MCI 和认知正常的患病率分别为 33.9%、31.1%和 34.9%。认知正常的患者与认知异常的患者之间的基础肺功能没有差异(FEV1 1.53±0.39 与 1.45±0.32 L)。在认知异常的患者中,MCI 或痴呆患者的特征没有差异。

结论

COPD 患者认知障碍的患病率很高。RCS 成功地识别了 COPD 中的认知障碍。我们建议常规对 COPD 患者进行 RCS 检查。

相似文献

1
Assessment of Cognitive Impairment in Patients with Chronic Obstructive Pulmonary Disease Using the Rapid Cognitive Screen.使用快速认知筛查评估慢性阻塞性肺疾病患者的认知障碍。
J Nutr Health Aging. 2019;23(1):102-104. doi: 10.1007/s12603-018-1146-x.
2
Cognitive Impairment in Chronic Obstructive Pulmonary Disease and Chronic Heart Failure: A Systematic Review and Meta-analysis of Observational Studies.慢性阻塞性肺疾病和慢性心力衰竭中的认知障碍:观察性研究的系统评价和荟萃分析
J Am Med Dir Assoc. 2017 May 1;18(5):451.e1-451.e11. doi: 10.1016/j.jamda.2017.01.014. Epub 2017 Mar 11.
3
The impact of cognitive impairment on self-management in chronic obstructive pulmonary disease: A systematic review.认知障碍对慢性阻塞性肺疾病自我管理的影响:一项系统综述。
Respir Med. 2017 Aug;129:130-139. doi: 10.1016/j.rmed.2017.06.006. Epub 2017 Jun 15.
4
Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysis.慢性阻塞性肺疾病的长效吸入疗法(β受体激动剂、抗胆碱能药物和类固醇):一项网状荟萃分析。
Cochrane Database Syst Rev. 2014 Mar 26;2014(3):CD010844. doi: 10.1002/14651858.CD010844.pub2.
5
Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease.噻托溴铵与长效β受体激动剂治疗稳定期慢性阻塞性肺疾病的比较
Cochrane Database Syst Rev. 2012 Sep 12;2012(9):CD009157. doi: 10.1002/14651858.CD009157.pub2.
6
Vitamin E for Alzheimer's dementia and mild cognitive impairment.维生素E用于治疗阿尔茨海默病性痴呆和轻度认知障碍。
Cochrane Database Syst Rev. 2017 Apr 18;4(4):CD002854. doi: 10.1002/14651858.CD002854.pub5.
7
Efficacy of nicergoline in dementia and other age associated forms of cognitive impairment.尼麦角林治疗痴呆及其他与年龄相关的认知障碍形式的疗效。
Cochrane Database Syst Rev. 2001;2001(4):CD003159. doi: 10.1002/14651858.CD003159.
8
Mild cognitive impairment is not predictive of dementia up to 15 years after subthalamic deep brain stimulation in Parkinson's disease.在帕金森病中,丘脑底核深部脑刺激术后长达15年的时间里,轻度认知障碍并不能预测痴呆。
J Parkinsons Dis. 2025 Jun;15(4):879-891. doi: 10.1177/1877718X251334049. Epub 2025 May 20.
9
Multi-domain interventions for the prevention of dementia and cognitive decline.多领域干预措施预防痴呆和认知能力下降。
Cochrane Database Syst Rev. 2021 Nov 8;11(11):CD013572. doi: 10.1002/14651858.CD013572.pub2.
10
Vitamin E for Alzheimer's dementia and mild cognitive impairment.维生素E用于治疗阿尔茨海默病性痴呆和轻度认知障碍。
Cochrane Database Syst Rev. 2017 Jan 27;1(1):CD002854. doi: 10.1002/14651858.CD002854.pub4.

引用本文的文献

1
Cerebral neurovascular alterations in stable chronic obstructive pulmonary disease: a preliminary fMRI study.稳定期慢性阻塞性肺疾病患者的脑血流动力学改变:一项初步的 fMRI 研究。
PeerJ. 2022 Nov 14;10:e14249. doi: 10.7717/peerj.14249. eCollection 2022.
2
The emerging role of nebulization for maintenance treatment of chronic obstructive pulmonary disease at home.雾化吸入在慢性阻塞性肺疾病家庭维持治疗中的新作用。
Lung India. 2021 Mar-Apr;38(2):168-173. doi: 10.4103/lungindia.lungindia_68_20.

本文引用的文献

1
Device errors in asthma and COPD: systematic literature review and meta-analysis.哮喘和 COPD 中的器械错误:系统文献回顾和荟萃分析。
NPJ Prim Care Respir Med. 2017 Apr 3;27(1):22. doi: 10.1038/s41533-017-0016-z.
2
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary.慢性阻塞性肺疾病全球策略:诊断、管理与预防 2017 年报告。GOLD 执行摘要。
Am J Respir Crit Care Med. 2017 Mar 1;195(5):557-582. doi: 10.1164/rccm.201701-0218PP.
3
The Rapid Cognitive Screen (RCS): A Point-of-Care Screening for Dementia and Mild Cognitive Impairment.
快速认知筛查(RCS):一种用于痴呆和轻度认知障碍的即时护理筛查方法。
J Nutr Health Aging. 2015 Aug;19(7):741-4. doi: 10.1007/s12603-015-0564-2.
4
COPD comorbidities network.COPD 合并症网络。
Eur Respir J. 2015 Sep;46(3):640-50. doi: 10.1183/09031936.00171614. Epub 2015 Jul 9.
5
An official American Thoracic Society/European Respiratory Society statement: research questions in COPD.美国胸科学会/欧洲呼吸学会官方声明:慢性阻塞性肺疾病的研究问题
Eur Respir Rev. 2015 Jun;24(136):159-72. doi: 10.1183/16000617.00000315.
6
Chronic obstructive pulmonary disease and association with mild cognitive impairment: the Mayo Clinic Study of Aging.慢性阻塞性肺疾病与轻度认知障碍的关系:梅奥诊所老龄化研究。
Mayo Clin Proc. 2013 Nov;88(11):1222-30. doi: 10.1016/j.mayocp.2013.08.012.
7
COPD assessment test --rationale, development, validation and performance.慢性阻塞性肺疾病评估测试——基本原理、开发、验证与性能
COPD. 2013 Apr;10(2):269-71. doi: 10.3109/15412555.2013.776920.
8
Cognitive dysfunction in patients hospitalized with acute exacerbation of COPD.慢性阻塞性肺疾病急性加重住院患者的认知功能障碍。
Chest. 2013 Jul;144(1):119-127. doi: 10.1378/chest.12-2099.
9
Teaching inhaler use in chronic obstructive pulmonary disease patients.对慢性阻塞性肺疾病患者进行吸入器使用的教学。
J Am Acad Nurse Pract. 2012 Feb;24(2):113-20. doi: 10.1111/j.1745-7599.2011.00681.x. Epub 2011 Dec 19.
10
Cognitive function in COPD.COPD 患者的认知功能。
Eur Respir J. 2010 Apr;35(4):913-22. doi: 10.1183/09031936.00125109.